159 related articles for article (PubMed ID: 37572175)
21. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
[TBL] [Abstract][Full Text] [Related]
22. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
Kwon HJ; Kim EK; Kwak JY
Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369
[TBL] [Abstract][Full Text] [Related]
23. Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management.
Chiosea S; Hodak SP; Yip L; Abraham D; Baldwin C; Baloch Z; Gulec SA; Hannoush ZC; Haugen BR; Joseph L; Kargi AY; Khanafshar E; Livhits MJ; McIver B; Patel K; Patel SG; Randolph GW; Shaha AR; Sharma J; Stathatos N; van Zante A; Carty SE; Nikiforov YE; Nikiforova MN
J Clin Endocrinol Metab; 2023 Oct; 108(11):2999-3008. PubMed ID: 37071871
[TBL] [Abstract][Full Text] [Related]
24. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
Kim SY; Kim EK; Kwak JY; Moon HJ; Yoon JH
Surgery; 2015 Feb; 157(2):354-61. PubMed ID: 25616949
[TBL] [Abstract][Full Text] [Related]
25. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5].
Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894
[No Abstract] [Full Text] [Related]
26. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
[TBL] [Abstract][Full Text] [Related]
27. BRAF
Lu Y; Guo X; Yang M; Wang K; Cao G; Liu Y; Hou X; Chen L; Liang K
Sci Rep; 2023 Oct; 13(1):17129. PubMed ID: 37816788
[TBL] [Abstract][Full Text] [Related]
28. Pyrosequencing analysis for detection of a BRAFV600E mutation in an FNAB specimen of thyroid nodules.
Kim SK; Kim DL; Han HS; Kim WS; Kim SJ; Moon WJ; Oh SY; Hwang TS
Diagn Mol Pathol; 2008 Jun; 17(2):118-25. PubMed ID: 18382358
[TBL] [Abstract][Full Text] [Related]
29. Significance of BRAF V600E Mutation and Cytomorphological Features for the Optimization of Papillary Thyroid Cancer Diagnostics in Cytologically Indeterminate Thyroid Nodules.
Beiša A; Kvietkauskas M; Beiša V; Stoškus M; Ostanevičiūtė E; Jasiūnas E; Griškevičius L; Šeinin D; Šileikytė A; Strupas K
Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):247-254. PubMed ID: 29566402
[TBL] [Abstract][Full Text] [Related]
30. Role of gene expression profiling in defining indeterminate thyroid nodules in addition to BRAF analysis.
Borrelli N; Ugolini C; Giannini R; Antonelli A; Giordano M; Sensi E; Torregrossa L; Fallahi P; Miccoli P; Basolo F
Cancer Cytopathol; 2016 May; 124(5):340-9. PubMed ID: 26749005
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic value of thyroid imaging reporting and data system combined with BRAF
Wu L; Shu H; Chen W; Gao Y; Yuan Y; Li X; Lu W; Ye X; Deng H
Sci Rep; 2022 Apr; 12(1):5934. PubMed ID: 35395862
[TBL] [Abstract][Full Text] [Related]
32. BRAF-mutated carcinomas among thyroid nodules with prior indeterminate FNA report: a systematic review and meta-analysis.
Trimboli P; Treglia G; Condorelli E; Romanelli F; Crescenzi A; Bongiovanni M; Giovanella L
Clin Endocrinol (Oxf); 2016 Mar; 84(3):315-20. PubMed ID: 25920006
[TBL] [Abstract][Full Text] [Related]
33. Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis?
Yoon JH; Kim EK; Moon HJ; Kwak JY
PLoS One; 2013; 8(3):e58592. PubMed ID: 23505540
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the Clinical Validity of Droplet Digital PCR to ARMS-PCR for BRAF V600E Mutation Detection in Thyroid Nodules.
Li X; Du H; Luo J; Ding W; Lai B; He J; Xu S; Zhang Y
J Clin Lab Anal; 2020 Nov; 34(11):e23458. PubMed ID: 32671901
[TBL] [Abstract][Full Text] [Related]
35. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
[TBL] [Abstract][Full Text] [Related]
36. BRAF
Zhao CK; Zheng JY; Sun LP; Xu RY; Wei Q; Xu HX
Cancer Med; 2019 Sep; 8(12):5577-5589. PubMed ID: 31397092
[TBL] [Abstract][Full Text] [Related]
37. High BRAFV600E mutation frequency in Chinese patients with papillary thyroid carcinoma increases diagnostic efficacy in cytologically indeterminate thyroid nodules.
Li XJ; Mao XD; Chen GF; Wang QF; Chu XQ; Hu X; Ding WB; Zeng Z; Wang JH; Xu SH; Liu C
Medicine (Baltimore); 2019 Jul; 98(28):e16343. PubMed ID: 31305422
[TBL] [Abstract][Full Text] [Related]
38. BRAF mutation analysis in thyroid nodules with indeterminate cytology: our experience on surgical management of patients with thyroid nodules from an area of borderline iodine deficiency.
Agretti P; Niccolai F; Rago T; De Marco G; Molinaro A; Scutari M; Di Cosmo C; Di Coscio G; Vitale M; Maccheroni M; Vitti P; Tonacchera M
J Endocrinol Invest; 2014 Oct; 37(10):1009-14. PubMed ID: 25194426
[TBL] [Abstract][Full Text] [Related]
39. Cytological features and nuclear scores: Diagnostic tools in preoperative fine needle aspiration of indeterminate thyroid nodules with RAS or BRAF K601E mutations?
Ravella L; Lopez J; Descotes F; Giai J; Lapras V; Denier ML; Borson-Chazot F; Lifante JC; Decaussin-Petrucci M
Cytopathology; 2021 Jan; 32(1):37-44. PubMed ID: 32803788
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY
Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
